90 Miles From Tyranny : COVID-19 Can Be Stopped Without Massive Vaccination: Dr. Peter McCullough

infinite scrolling

Friday, January 28, 2022

COVID-19 Can Be Stopped Without Massive Vaccination: Dr. Peter McCullough

Dr. Peter McCullough in an interview with NTD's Capitol Reports program during "Defeat The Mandate" rally in Washington D.C., on Jan. 23, 2022.

COVID-19 can be stopped without massive vaccination, renowned cardiologist and epidemiologist Dr. Peter McCullough told NTD’s “Capitol Report” program during the “Defeat the Mandates” march in Washington D.C., on Jan. 23.

According to McCullough, early treatment and natural immunity are safe and effective against COVID-19, but federal health agencies have ignored these in a push for vaccines, the broad use of which is not needed.

“The government has certainly been in an oblivion in terms of early treatment,” he said.

Thousands of people turned out to march in protest against COVID-19 vaccine mandates—one of the largest U.S. events against the mandates since the start of the pandemic.

“Our CDC, FDA, and NIH have had no effective messaging on early treatment, even the emergency use authorized monoclonal antibodies, which are safe and effective,” McCullough said. “And even on the new Merck and Pfizer drugs, which they’re basically absent in terms of the media, despite being recently distributed across the United States.”

Early effective treatment of any disease can help avert progression to more serious illness, with an additional benefit of reducing the burden on health care systems.

The Centers for Disease Control and Prevention (CDC) stated on its website that according to the COVID-19 Treatment Guidelines published by the National Institutes of Health (NIH), “current clinical management of COVID-19 consists of infection prevention and control measures and supportive care, including supplemental oxygen and mechanical ventilatory support when indicated.”

The Food and Drug Administration (FDA) has approved one drug, remdesivir (Veklury), to treat COVID-19 in hospitalized patients, the CDC continued.

On Monday, the FDA announced that it is restricting the use of two monoclonal antibody treatments for COVID-19, saying data show such treatments are “highly unlikely” to be active against the Omicron variant.

A crowd gathers at Lincoln Memorial for the “Defeat the Mandates” rally in Washington on Jan. 23, 2022. (Lynn Lin/NTD)

McCullough said that highly qualified doctors have done the research and have shown that “early treatment can end this pandemic by reducing the intensity and severity of disease and reducing the chances of hospitalization and death in...

Read More HERE

No comments: